Cyclacel Pharmaceuticals
CYCC
CYCC
16 hedge funds and large institutions have $371K invested in Cyclacel Pharmaceuticals in 2024 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 1 closing their positions.
Holders
16
Holders Change
+4
Holders Change %
+33.33%
% of All Funds
0.23%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
1
Reduced
2
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
AC
1
Armistice Capital
New York
|
$217K |
| 2 |
2
UBS Group
Zurich,
Switzerland
|
$61.5K |
| 3 |
3
Citadel Advisors
Miami,
Florida
|
$19.9K |
| 4 |
HF
4
HRT Financial
New York
|
$17K |
| 5 |
AWM
5
Activest Wealth Management
Aventure,
Florida
|
$215 |
Top Sellers
| 1 |
1
Renaissance Technologies
New York
|
$0 |
| 2 |
TRCT
2
Tower Research Capital (TRC)
New York
|
$5.69K |
| 3 |
3
Wells Fargo
San Francisco,
California
|
$53 |
